Biotech Gainers: TENX Rebound, KURA Momentum, AVXL Profit, RNXT Data Drive Gains

Biotech/healthcare top gainers highlighted include Tenax Therapeutics, rebounding sharply after a recent Phase 3 trial setback, and Kura Oncology, which is up on continued Komzifti adoption. Anavex Life Sciences also advanced after returning to profitability. Overall tone is mildly positive driven by company-specific progress rather than a clear sector-wide catalyst.